Canndeo is an Australian medicinal cannabis company established to supply high quality imported medicinal cannabis into Australia, as well as developing Australian production of medicinal cannabis.
Canndeo partners with leading international organisations to provide medicinal cannabis formulations that may assist in a range of medical indications.
With a strong commitment to providing evidence as well as quality, Canndeo continues to invest in building clinical data on the use of medicinal cannabis formulations to support more informed prescribing.
Canndeo focuses on CBD formulations, which are not psychoactive and used internationally by patients for a range of indications and symptoms including epilepsy, anxiety disorders, pain and inflammation.
Canndeo partners internationally to supply THC-containing formulations into Australia. THC- containing formulations been used internationally by patients in a range of indications and symptoms including antiemetic, pain management, appetite stimulant, spasticity management as well as use in palliative care.
We are dedicated to supporting patients, doctors, pharmacists and health care professionals with formulations, training and evidence to enable informed decision making with medicinal cannabis.